Urogen Pharma Ltd.
Records under this name other than the patents Urogen Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
Showing 1 to 8 of 8 · Back to Urogen Pharma Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,268,745 | Material and Method for Treating Internal Cavities Term ended Term ended Oct 26, 2026 · High confidence | Term ended | Term ended Oct 26, 2026 | High confidence |
| US 12,440,568 | Material and Method for Treating Internal Cavities Term ended Term ended Oct 26, 2026 · High confidence | Term ended | Term ended Oct 26, 2026 | High confidence |
| US 8,361,490 | Biocompatible Drug Delivery Apparatus and Methods Term ended Term ended Mar 26, 2026 · High confidence | Term ended | Term ended Mar 26, 2026 | High confidence |
| US 8,936,566 | Biocompatible Drug Delivery Apparatus and Methods Term ended Term ended Sep 16, 2024 · High confidence | Term ended | Term ended Sep 16, 2024 | High confidence |
| US 9,011,411 | Methods for Treatment of Bladder Cancer Term ended Term ended Sep 16, 2024 · High confidence | Term ended | Term ended Sep 16, 2024 | High confidence |
| US 9,884,028 | Methods for Treatment of Bladder Cancer Term ended Term ended Sep 16, 2024 · High confidence | Term ended | Term ended Sep 16, 2024 | High confidence |
| US 9,173,935 | Phospholipid Drug Analogs Lapsed on the fee record Ended Nov 3, 2023 · Medium confidence | Lapsed on the fee record | Ended Nov 3, 2023 | Medium confidence |
| US 9,050,319 | Phospholipid Drug Analogs Lapsed on the fee record Ended Jun 9, 2023 · Medium confidence | Lapsed on the fee record | Ended Jun 9, 2023 | Medium confidence |